Home

Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Hot Sales

Chemical Structure Cat. No. Product Name CAS No.
3,4-Diaminofurazan Chemical Structure
BCP00227 3,4-Diaminofurazan 17220-38-1
3,4-Diaminofurazan is a building block used to prepare magnesium and zinc alkynylated salicylaldehyde-diamine Schiff base complexes.
APR-246 Chemical Structure
BCP20294 APR-246 5291-32-7
APR-246 restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. PRIMA-1Met also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
Temsirolimus Chemical Structure
BCP25281 Temsirolimus 162635-04-3
Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay.
Vortioxetine Chemical Structure
BCP05996 Vortioxetine 508233-74-7
Vortioxetine (Lu AA21004) is an investigational novel antidepressant with multimodal activity that functions as a 5-HT3, 5-HT7 and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and inhibitor of the 5-HT transporter in vitro.
Favipiravir Chemical Structure
BCP02422 Favipiravir 259793-96-9
Favipiravir, also known as T705, is a RNA-directed RNA polymerase NS5B inhibitor
Delamanid Chemical Structure
BCP07838 Delamanid 681492-22-8
Delamanid, a newer mycobacterial cell wall synthesis inhibitor, inhibits the synthesisi of mucolic acids, cruciala component of the cell wall of the Mycobacterium tuberculosis complex.
Repotrectinib Chemical Structure
BCP19778 Repotrectinib 1802220-02-5
TPX-0005 is a potent ALK/ROS1/TRK inhibitor, with IC50 of 5.3 nM, 1.01 nM, 1.26 nM and 1.08 nM for SRC, WT ALK, ALK G1202R and ALK L1196M, respectively.
Adavosertib Chemical Structure
BCP01928 Adavosertib 955365-80-7
MK-1775 is a potent and selective Wee1 kinase inhibitor with an IC50 of 5.2 nM.
LOXO-195 Chemical Structure
BCP20662 LOXO-195 2097002-61-2
LOXO-195 is a next-generation TRK kinase (TKI) inhibitor, with IC50s of 0.6±0.1 nM, <2.5 nM for TRKA and TRKC respectively.
Bevacizumab Chemical Structure
BCP07998 Bevacizumab 216974-75-3
Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).
D-glucono-1,4-lactone Chemical Structure
BCP17475 D-glucono-1,4-lactone 1198-69-2
D-glucono-1,4-lactone is a gluconolactone derived form D-gluconic acid.
Resiquimod Chemical Structure
BCP09103 Resiquimod 144875-48-9
BMS-986205 Chemical Structure
BCP20339 BMS-986205 1923833-60-6
BMS-986205 is a selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor.
Cabazitaxel Chemical Structure
BCP27641 Cabazitaxel 183133-96-2
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
Furafylline Chemical Structure
BCP20952 Furafylline 80288-49-9
Furafylline is a potent and selective inhibitor of human cytochrome P450IA2 with an IC50 of 0.07 μM.
GSK2330672 Chemical Structure
BCP17155 GSK2330672 1345982-69-5
GSK2330672 is a highly potent, nonabsorbable ASBT(apical sodium-dependent bile acid transporter) inhibitor (hASBT IC50=42 ± 3 nM) which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.
Nicotinamide Riboside Chloride Chemical Structure
BCP20094 Nicotinamide Riboside Chloride 23111-00-4
Nicotinamide riboside is a pyridine-nucleoside form of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+.
Brivaracetam Chemical Structure
BCP14251 Brivaracetam 357336-20-0
Brivaracetam(UCB-34714) is a 4-substituted pyrrolidone butanamide as agent with significant antiepileptic activity; high affinity SV2A ligand and also shows an ability to inhibit Na+ channels.
NSC 133723 Chemical Structure
BCP02884 NSC 133723 19741-14-1
NSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
AZD0156 Chemical Structure
BCP18990 AZD0156 1821428-35-6
AZD0156 is an oral, potent and selective ATM kinase inhibitor, inhibiting the kinase activity of ATM and ATM-mediated signaling, preventing DNA damage checkpoint activation, and disrupting DNA damage repair, inducing tumor cell apoptosis, and leading to cell death in ATM-overexpressing tumor cells.
123下一页共 41 条记录 1 / 3 页 
0086-13720134139